MELISSA HOFERER: Open Payments
NPI 1386992303 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 44 payments from 15 companies in 2025. Trend: 2023 $721 · 2024 $435 · 2025 $1,028
Food & beverage: $938Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $475 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Fresenius USA Marketing, Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Insmed, Inc. | 2 | $44 |
| Grifols USA, LLC | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Vifor Pharma, Inc. | 2 | $33 |
Products named: TEZSPIRE, DUPIXENT, FASENRA, BREZTRI, AIRSUPRA, VELPHORO, NUCALA, Arikayce.
Industry payments across NE — which companies pay providers there.
